DIA
Drug Information Association Logo

THE SOCIETAL PERSPECTIVE ON PERSONALISED MEDICINE - MANAGING THE PARADIGM SHIFT

Track:
Personalised Medicine: Drug-companion diagnostics combinations

Day & Time:
March 26, 4:00PM - 5:30PM (Central European Standard Time)

Session Number:
0504

Room Number:
Room I

Type:
Session

Title:
THE SOCIETAL PERSPECTIVE ON PERSONALISED MEDICINE - MANAGING THE PARADIGM SHIFT

Chair(s):
Brian Godman, PhD
Senior Researcher
Karolinska Institutet, Sweden

Description:
The introduction of personalised medicine asks for adoptions of many stakeholders. How are we going to manage the paradigm shift in the healthcare sector to assure fast adoption of personalised medicine?

Presentation(s) & Speaker(s):
Can Society Afford Personalised Medicine?
Claudia Wild
Ludwig Boltzmann Institute for Health Technology Assessment, Austria

Patient Representative’s View on Personalised Medicine
Durhane Wong-Rieger, PhD, MA
President and Chief Executive Officer
Canadian Organization For Rare Disorders (CORD), Canada

Industry-Society Interactions are Essential to Make Promises of Personalised Medicine Come True
Alexander Roediger, MA, MBA
Director European Union Affairs
MSD Europe, Inc., Belgium

Introduction of Personalised Medicine in East European Economies
Maria Judit Molnar
Vice Rector
Semmelweiss University, Hungary